Tax season kicks off with 8% smaller refunds
After one week, the percentage of households getting tax refunds is similar to last year
All Posts in "Markets"
May asks lawmakers for more time to retool Brexit deal
Aim is to hold off on key Parliament vote for two more weeks
These are some of the best home-base cities for travelers
Globe-trotters don’t have to live in the big metros
SunTrust and BB&T are merging — here’s what customers need to know
‘This deal’s going to open the floodgates to a number of more bank acquisitions and a renewed wave of consolidation.’
Inflation? What inflation? Falling price pressures clear runway for economy in 2019
Waning inflation gives Fed excuse to keep interest rates low
Pot, soda and videogame earnings are on Wall Street’s to-do list
Aurora Cannabis and Canopy Gorwth to show off legal-pot earnings; Pepsi and Coke square off; Nvidia and Activision follow rough week for videogames
Why stock-market traders are already bracing for a make-or-break month in March
Will the stock market kick off March like a lion and leave like a lamb?
Stocks bounce back from lows to close mostly higher; Dow gains for 7th week
Shares of Hasbro fall as those of rival toy maker Mattel surge
Why the dollar is back on the rise despite the Fed’s dovish turn
Demand for a haven appears to outweigh rate pause
Cisco earnings: Tariffs and demand could weigh on outlook
Switch and security strength will be needed as analysts doubt fiscal third-quarter forecast
Galapagos investor signals intent to influence company’s control, argues the biotech is ‘deeply undervalued’
Dexcom’s Stelo, its first over-the-counter glucose monitor, hits the market
Procept BioRobotics stock jumps on FDA nod for prostate surgery system
Understanding how pythons swallow massive meals may help develop new human heart medicines
Lykos’ woes mount as FDA expands probe into its MDMA-based research: WSJ
After phase 2 fail, Actinogen reports new data in bid to salvage depression drug xanamem
MBX files for IPO, seeking cash to take challenger to Ascendis’ Yorvipath into phase 3
Preclinical gene editor Tome is laying off 131 staffers, virtually its entire workforce
Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
Tweaking one setting on mechanical ventilators may help protect patients from lung injury